CytoDyn Inc.
Extract: Update, Proxy Fight Director Nomination from a DFAN14A on 09/02/2021   Download
SEC Document
SEC Filing

The participants named herein (collectively, the “Participants”), have filed a definitive proxy statement and accompanying WHITE proxy card with the Securities and Exchange Commission to be used to solicit votes for the election of its slate of director nominees at the 2021 annual meeting of stockholders of CytoDyn Inc., a Delaware corporation (the “Company”).

 

 

 

 

 

 

On September 1, 2021 (after 5:30 PM Eastern Time) Paul Rosenbaum, who is one of the Participants, sent the following e-mail to certain stockholders of the Company.